Browse > Article

Induction of Apoptosis by (-)-epigallocatechin-3-gallate in HL-60 Cells  

이해미 (연세대학교 식품영양학과)
김연정 (연세대학교 식품영양학과)
박태선 (연세대학교 식품영양학과)
Publication Information
Journal of Nutrition and Health / v.36, no.4, 2003 , pp. 382-388 More about this Journal
Abstract
(-)-Epigallocatechin-3-gallate (EGCG) is a polyphenolic compound found in peen tea leaves, and has been known to be one of the most potent catechin species which inhibits cell growth most possibly through an apoptotic cell death. We investigated the apoptotic activity of (-)-EGCG on the human myeloid leukemia cell line, HL-60. Our results of MTT test indicated that (-)-EGCG had a significant antiproliferation effect in HL-60 cells with $IC_{50}$/ (50% inhibition concentration) value of 65 $\mu$M. Giemsa statining of HL-60 cells treated with (-)-EGCG (100 $\mu$M) for 6hrs showed a typical apoptosis-specific morphological change including shrinkage of the cytoplasm, membrane blobbing and compaction of the nuclear chromatin. The DNA fragmentation was observed from the agarose gel electrophoresis of cells treated with (-)-EGCG for 3hrs or longer, and was progressed to a greater degree as treatment time increases. Treatment of the cells with (-)-EGCG (100 $\mu$M) resulted in a rapid release of mitochondrial cytochrome c into the cytosol, and a subsequent cleavage of caspase-3 to an active form in a treatment-time dependent manner. (-)-EGCG (100 $\mu$M) also stimulated proteolytic cleavage of poly-(ADP-ribose) polymerase (PARP) to an active form in HL-60 cells. Tlken together, (-)-EGCG appears to induce the apoptosis in human myeloid leukemia cells via a caspase-dependent pathway. These results suggest the possible application of (-)-EGCG, the major active compound in green tea, as an antiproliferative agent for cancer prevention.
Keywords
HL-60 cells; apoptosis; (-)-epigallocatechin-3-gallate; caspase-3; poly-(ADP-ribose)-polymerase;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Chung LY, Cheung TC, Kong SK, Fung KP, Choy YM, Chan ZY, Kwok TT. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci 68: 1207-1214, 2001   DOI   ScienceOn
2 Chen W, Dong Z, Valcic S, Timmermann BN, Gowden GT. inhibition of ultraviolet B -induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol Carcinog 24: 79-84, 1999   DOI   ScienceOn
3 Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys 376: 338-346, 2000   DOI   ScienceOn
4 Gupta S, Hussain T, Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate -induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410(1): 177-185, 2003   DOI   ScienceOn
5 Suzuki N, Urano J, Tamanol F. Farnesyltransferase inhibitors induce cytochrome C release and caspase 3 activation preferentially in transformed cells. Proc Natl Acad Sci USA 95: 15356-15361, 1998   DOI   ScienceOn
6 Kroemer G, Martinez AC, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 18: 44-51, 1997   DOI   ScienceOn
7 Mukhtar H, Ahmad N. Mechanism of cancer chemopreventive activity of green tea, Proc Soc Exp Biol Med 220: 234-238, 1999   DOI   ScienceOn
8 Samali A, Zhivotoxvsky B, Jones D, Nagata S, Orrenius S. Apoptosis: cell death defined by caspase activation. Cell Death Differ 6: 495-496, 1999   DOI   ScienceOn
9 Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19: 611-616, 1998   DOI   ScienceOn
10 Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994   DOI   ScienceOn
11 Nicholson DW, Ali A, Thomberry NA, Vaillancourt JP, Ding CK Gallant M, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995   DOI   ScienceOn
12 Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability is a central coordinating event of apoptosis. J Exp Med 184: 1155-1160, 1996   DOI   ScienceOn
13 Yoo HG, Shin BA, Park JC, Kim HS, Kim WJ, Chay KO, Ahn BW, Park RK, Ellis LM, Jung YD. Induction of apoptosis by the green tea flavonol (-)-epigallocatechin-3-gallate in human endothelial ECV 304 cells. Anticancer Res 22(6A): 3373-8, 2002
14 Baliga BC, Kumar S. Role of Bcl-2 family of proteins in malignancy. Hematol Oncol 20(2) : 63-74, 2002   DOI   ScienceOn
15 Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, Drake L, Caughman GB, Schuster GS. Chemoprevention of oral cancer by green tea. Gen Dent 50(2): 140-6, 2002
16 Preventing neural tube defects:the importance of periconceptional folic acid supplements /
[ Locksmith GJ;Duff P ] / Obstet Gynecol   DOI
17 Genetic Polymorphisms of methylenetetrahydrofolate reductase (MTHER) and methionine synthase reductase (MTRR) in ethnic populations in Texas;A report of a novel MTHER polymorlhic site, G1793A /
[ Rady PL;Szucs S;Grady J;Hudnall SD;Kellner LH;Nitowsky H;Tyring SK;Matalon RK ] / Am J Med Genes   DOI
18 Homocysteine metabolism in pregnancies complicated by neural tube defects /
[ Mill JL;McPartlin JM;Kirke PN ] / Lancet   DOI
19 Homocysteine and methylmalonic acid levels in pregnant Npali women. Should cobalamin supplementation be considered? /
[ Bondevik GT;Schneede J;Refsum H;Lie RT;Ulstein M;Kvale G ] / Eur J Clin Nutr   DOI   ScienceOn
20 Hyperhomocusteinaemia /
[ Perry,D.J. ] / Baillieres Clin Heamatol
21 Plasma total homocysteine, pregnancy complications and adverse pregnancy outcomes:the Hordaland Homocysteine /
[ Vollset SE;Refsum H;Irgens LM;Emblem BM;Tverdal A;Gjessing HK;Monsen ALB;Ueland PM ] / Am J Clin Nutr
22 Changes in homocysteine levels during normal pregnancy /
[ Walker MC;Smith GN;Perkins SL;Keely EJ;Garner PR ] / Am J Obstet Gynecol   DOI
23 Relationship between vitamin B6 status of maternal-umbilical cord plasma and pregnancy outcomes /
[ Ahn HS;Lee GJ;Kim YT ] / Korean J Nutr
24 Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a histtory of preeclampsia or fetal growth restriction /
[ Leena M;Riyazi N;de Vries JIP;Jakobs C;van Geijn HP;Dekker GA ] / Am J Obstet Gynecol   DOI
25 Serum folate levels of maternal-umbilical cord blood and pregnancy outcomes /
[ Ahn HS;Kim JS;Lee GJ;Kim YT ] / Korean J Nutr   과학기술학회마을
26 Biological and clinical implications of the MTHFR C666T polymorphism /
[ Ueland PM;Hustad D;Schneede J;Refsum H;Vollset SE ] / Trends in Pharmacol Sci   DOI
27 Homocysteine induces congenital defects of the heart and neural tube:effect of folic acid /
[ Rosequist TH;Kirke PN ] / Proc Natl Acad Sci USA   DOI
28 Hyperhomocysteinemia:A risk factor in women with unexplained recurrent early pregnancy loss /
[ Wouters MG;Boers GH;Blom HJ;Trijibels FJ;Thomas CM;Borm GF;Steegers-Theuissen RP;Eskes TK ] / Fertil Steril
29 The placenta in maternal hylerhomocysteinaemia /
[ Khong TY;Hague WM ] / Br J Obstet Gynaecol   DOI
30 Protein-bound homocyst(e)ine /
[ Kang SS;Wong PWK;Cook HY;Norusis M;Messer JV ] / J Clin Invest   DOI
31 Folic acid:influence on the outcome of pregnancy /
[ Scholl TO;Johson WG ] / Am J Clin Nutr
32 The methionine synthase reductase (MTRR) A66G polymorphism is a movel genetic determinant of plasma homocysteine concenttrations /
[ Gaughan DJ;Kluijtmans LA;Barbaux S;McMaster D;Young IS;Yarnell JW;Evans A;Whitehead AS ] / Atherosclerosis   DOI
33 Hyperthomocysteunemia:A risk factor for placental abruption or infarction /
[ Goffojn-Wesel TAW;Wouters MGAJ;v.d.Molen EF;Spuijbroek MDEH;Steegers-Theunissen RPM;Blom HJ;Boers GHJ;Eskes TKAB ] / Eur J Obstet Gynecol   DOI
34 Maternal vitamin B6 intake and vitamin B6 level in maternal, umbilical cord plasma and placenta /
[ Ahn HS;Lee GJ;Chung HW ] / Korean J Nutr
35 Hyperhomocysteinemia and pregnancy-review of our present understanding and therapeutic implications /
[ Aubard Y;Darodes N;Cataloube M ] / Eur J Obstet Gynecol   DOI
36 A candidate genetic risk factor for vascular disease:A common mutation in methylenetetrahydrofolate reductase /
[ Frosst P;Blom HJ;Milos R;Goyette P;Sheppard C;Matthews R;Moers GJ;den Heijer M;Kluijtmans LA;van den Heuvel LP;Rozen R ] / Nat Genet   DOI   ScienceOn
37 Determination of free and total homocysteine in human plasma by high performance liquid chromatograpfy with fluorescence detection /
[ Araki A;Sako Y ] / J Chromatogr   DOI
38 Is homocysteine a biomarker for identifying women at risk of complications and adverse pregnancy outcomes? /
[ Piccian MF ] / Am J Clin Nutr
39 Acute hyperhomocysteinaemia and endothelial dysfunction /
[ Chambers JC;McGregor A;Jean-Marie J;Kooner JS ] / Lancet   DOI   ScienceOn
40 Intrauterine groeth retardation, perinatal death, and maternal homocysteine levels /
[ Burke G;Robinson K;Refwum H;Struart B;Drumm J;Graham I ] / N Eng J Med
41 Neural tube defects and a disturbed folate dependent homocyssteine metabolism /
[ van der Put NMJ;Blom HJ ] / Eur J Obstet Gunecol Reprod Biol
42 A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate atatus and homocysteinemia /
[ Chango A;Emery-Fillon N;de Courcy GP;Lambert D;Pfister M;Rosenblatt DS;Nicolas JP ] / Mol Genet Metab   DOI
43 A new HPLC-nethod for the simultaneous determination of B1-,B2- and B6-vitamers in serum and whole blood /
[ Botticher B;Botticher D ] / Int J Vitamin Nutr Res